Study Stopped
No participants recrui
Hearing Handicap in Patients With Single Sided Deafness
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
Single sided deafness (SSD) refers to asymmetrical hearing loss, where there is a significant worsening of hearing in one ear compared to the other. In Cambridge, the investigators see large numbers of patients with SSD caused by vestibular schwannomas, due to their affiliation with the Neuro-Otology Department, with over 100 new SSD patients being referred every year. Only a small number of studies have explored hearing handicap for those with SSD, and music appreciation has not been investigated, to the best of the investigators knowledge, in this patient group. In the limited number of studies conducted on those with single sided deafness, often only one or two outcome measures have been used, or the patient group has been small. The investigators have a large group of patients with a wide range of aetiologies who have completed several questionnaires as part of their treatment in the single sided deafness clinic and the investigators would like to analyse these data. At present there are different devices available on the NHS for the management of SSD and many studies have explored benefits of Bone Anchored Hearing Aids (BAHA). There is an under-representation of studies looking specifically at CROS aid devices which is relevant given the cost differences involved between devices. Study goals and objectives
- To find out what factors drive hearing handicap in SSD patients by analysing the results of several different well validated hearing handicap questionnaires
- To find out whether or not it is possible to change hearing handicap in this patient group by looking to see if there is an improvement in questionnaire scores post treatment.
- The investigators will also look at a sub-group who will be fitted with both traditional wired CROS aids and more up-to-date wireless aids which have been funded through a research grant, in order to assess whether these are more beneficial.
- The investigators will use a new questionnaire developed in-house to further explore the impact of single sided deafness on music appreciation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2014
CompletedStudy Start
First participant enrolled
August 1, 2015
CompletedFirst Posted
Study publicly available on registry
August 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedApril 7, 2017
April 1, 2017
1.5 years
September 3, 2014
April 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Abbreviated hearing aid benefit profile (APHAB)
Hearing aid benefit questionnaire
180 days
Speech and spatial qualities of hearing (SSQ)
Hearing aid benefit questionnaire
180 days
Tinnitus handicap inventory (THI)
Tinnitus questionnaire
180 days
Hearing handicap inventory (HHI)
Hearing aid benefit questionnaire
180 days
Hospital anxiety and depression scale (HADS)
Anxiety and depression questionnaire
180 days
Study Arms (1)
Hearing Aid
EXPERIMENTALCROS hearing aid
Interventions
Hearing aid comparison
Eligibility Criteria
You may qualify if:
- Patients who attend the single sided deafness clinic.
- Must have either no recordable hearing threshold levels on one side or a significant asymmetry.
- The 13 CROS aid trial patients must be post-operative vestibular schwannoma patients with an audiological 'dead ear' on the affected side.
You may not qualify if:
- Patients unable to give informed consent
- Patients under 18 years of age
- For the CROS aid trial, patients with any aetiology other than vestibular schwanomma, pre-operative vestibular schwanomma patients or vestibular schwanomma patents who still have residual hearing in the affected ear.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cambridge University Hospital NHS Trust, Audiology department
Cambridge, Cambridgeshire, CB7 5TT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark D Smith, MSc
Addenbrooke's Hospital, Cambridge, UK
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist Audiologist
Study Record Dates
First Submitted
September 3, 2014
First Posted
August 17, 2015
Study Start
August 1, 2015
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
April 7, 2017
Record last verified: 2017-04